In Brief: Interneuron
Executive Summary
Interneuron: Transfer of sublicense of Servier dexfenfluramine to AHP is progressing, following its purchase of American Cyanamid, who is the original sublicenser of dexfenfluramine from Interneuron, company reports. Under the licensing agreement between Servier and Interneuron, "Servier has the right to withdraw its consent to the sublicense in the event that any entity acquires stock in American Cyanamid sufficient to elect a majority" of Cyanamid's board of directors, according to Interneuron's 1994 annual report...